Navigation Links
Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)
Date:5/19/2009

The American Stem Cell Therapy Association (ASCTA) announced today the availability of the world's first clinical guidelines to allow U.S. doctors to safely begin using a patient's own stem cells to treat disease.

Broomfield, CO (PRWEB) May 19, 2009 -- The American Stem Cell Therapy Association (ASCTA) announced today the availability of the world's first clinical guidelines to allow U.S. doctors to safely begin using the patient's own stem cells to treat disease.

ASCTA was formed in response to the FDA's position that the patient's own stem cells are considered drugs and should be regulated as such. Strong opposition by physicians and patients worldwide motivated the effort to research and publish scientific guidelines that provide the medical community with standards under which adult stem cell therapy can be practiced safely. These stem cell therapy guidelines represent the world's first clinical guidelines designed to facilitate safe stem cell therapy practice. A key aspect of the document is the concept that adult stem cell therapy with the patient's own cells is governed under the practice of medicine, not under drug production guidelines.        

Barbara Hanson, the founder of StemCellPioneers, stated, "We are very excited to see the progress of these guidelines. They form the blueprint for access to safe stem cell therapy here in the U.S. by millions of patients whose lives depend on new medical approaches to diseases and conditions."

Since the ASCTA's recent announcement that it was producing guidelines for care with stem cells, the organization has been flooded with emails and calls from both patients and physicians expressing support for the effort. In addition, a patient-driven movement, called SafeStemCellsNow, has formed at SafeStemCellsNow and is rapidly growing as word of the movement has spread.

Adult stem cells can be processed with the same techniques commonly used in existing in-vitro fertilization (IVF) labs. "Like the human cells and tissue used in IVF, adult stem cells are not drugs," stated Christopher J. Centeno, M.D., a physician who worked on the guidelines and whose medical practice includes the use of the Regenexx procedure, which uses patients own stem cells to treat orthopedic conditions. "Making the stem cells in your own body a drug won't make them safer, will dramatically reduce availability of treatment, and will increase bureaucratic red tape." stated Dr. Centeno.

"ASCTA has established guidelines of the highest standards so that American doctors can begin treating patients in the safest manner and do so in the foreseeable future rather than years or decades later if left to federal quagmire," stated Zannos Grekos M.D., an American Cardiologist and Director of Cardiac and Vascular diseases at Regenocyte Therapeutic, a company successfully treating patients with heart disease such as congestive heart failure and lung disease such as pulmonary fibrosis, COPD, and pulmonary hypertension.

Adult stem cells have undergone much more research than embryonic stem cells and thus are closer to real world treatments. These adult stem cells are taken from the patient's own body (autologous) and ACSTA believes that they are therefore safest for use in treating patients.


About Safe Stem Cells NOW!
The Safe Stem Cells NOW! Movement was started by the American Stem Cell Therapy Association (ASCTA) and driven by its patient members. The movement's goal is to inform patients and physicians that their ability to access safe stem cell treatment is being heavily restricted by pharmaceutical industry agenda's and by the FDA. For more information, visit SafeStemCellsNOW.

About ASCTA
The ASCTA is a physician group comprised of various medical and surgical specialties whose goal is to bring safe stem cell therapy to patients by establishing laboratory and clinical guidelines. For more information, visit ASCTA.

About Barbara Hanson
Barbara Hanson is the founder of StemCellPioneers, the largest patient-moderated forum for stem cell discussion and support for those seeking, or who have received, stem cell treatment.

About Christopher Centeno, M.D.
Christopher Centeno, M.D. is a board certified pain management specialist in Colorado who utilizes The Regenexx Procedure, an adult stem cell therapy that is used to successfully treat bone, joint, back and ligament conditions and helps patients avoid the need for more invasive orthopedic surgery. Dr. Centeno has published numerous medical research papers on the clinical application of adult mesenchymal stem cells. More information on Dr. Centeno can be found at here.

About Zannos Grekos, M.D.
Zannos Grekos, MD, FAAC is an invasive cardiologist with extensive experience and training in the field of stem cell therapy. In collaboration with major international treatment and research centers, he has developed many of the protocols used for adult stem cell therapy throughout the world. Dr. Grekos also trains physicians in the evaluation and treatment of patients receiving stem cell therapy. He was recently appointed to the Science Advisory Board of the United States' Repair Stem Cell Institute and is a member of the International Society for Stem Cell Research (ISSCR). Dr. Grekos is also working with several members of Congress in promoting the Adult Stem cell Caucus to further educate our elected representatives on the safety and efficacy of adult stem cells. More information on Dr. Grekos can be found at Regenocyte .

MEDIA CONTACT:
Holly Hamann
720-290-0007

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2436694.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. KAPE to Honor High-Performing Pennsylvania Organizations
2. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
3. NanoSensors, Inc. Announces Reorganization of Executive Management Team and Redirection of Operations
4. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
7. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
8. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
9. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
10. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
11. Association of Clinical Research Organizations (ACRO) Elects New Officers for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)
(Date:4/26/2017)... Pa. , April 26, 2017  Genisphere ... delivery platform, has signed a collaborative and sponsored ... Dr. Silvia Muro . The overall goal ... and pharmacodynamics of various 3DNA designs and formulations ... involve targeting diseases of the vasculature as well ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... of L3 Healthcare, is pleased to announce the company is now a certified ... The iMedNet software certification enables the company’s clinical research team to build, ...
(Date:4/25/2017)... Gatos, California (PRWEB) , ... April 25, 2017 ... ... business, Analytical Services and Metrology Partners.     , Covalent’s Analytical Services unit ... Most samples can be measured within 24 hours of receipt. There are no ...
(Date:4/24/2017)... 2017  Dante Labs announced today the offer of whole ... $900). While American individuals have been able to access WGS ... access WGS below EUR 1,000. The sequencing includes ... information to make informed decisions about disease monitoring, prevention, nutrition, ... ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):